Carregant...

Management of arthralgias associated with aromatase inhibitor therapy

For the upfront adjuvant therapy of postmenopausal estrogen receptor–positive breast cancer, the third-generation aromatase inhibitors (ais) have shown a more favourable overall risk–benefit profile than has tamoxifen. Benefits of the ais include less frequent gynecologic, cerebrovascular, and throm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Thorne, C.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2007
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2140182/
https://ncbi.nlm.nih.gov/pubmed/18087604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!